510(k) K252627
K252627 is an FDA 510(k) premarket notification submitted by Inanovate, Inc. for the device "Lyme-ID IgG Test; Bio-ID800". The FDA issued a decision of Substantially Equivalent on November 14, 2025. The device falls under product code LSR (Reagent, Borrelia Serological Reagent), a Class II device regulated under 21 CFR 866.3830.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 14, 2025
- Date Received
- August 20, 2025
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Reagent, Borrelia Serological Reagent
- Device Class
- Class II
- Regulation Number
- 866.3830
- Review Panel
- MI
- Submission Type